The Respiratory Protection Effectiveness Clinical Trial (ResPECT): a cluster-randomized comparison of respirator and medical mask effectiveness against respiratory infections in healthcare personnel

Lewis J Radonovich Jr, Mary T Bessesen, Derek A Cummings, Aaron Eagan, Charlotte Gaydos, Cynthia Gibert, Geoffrey J Gorse, Ann-Christine Nyquist, Nicholas G Reich, Maria Rodrigues-Barradas, Connie Savor-Price, Ronald E Shaffer, Michael S Simberkoff, Trish M Perl, Lewis J Radonovich Jr, Mary T Bessesen, Derek A Cummings, Aaron Eagan, Charlotte Gaydos, Cynthia Gibert, Geoffrey J Gorse, Ann-Christine Nyquist, Nicholas G Reich, Maria Rodrigues-Barradas, Connie Savor-Price, Ronald E Shaffer, Michael S Simberkoff, Trish M Perl

Abstract

Background: Although N95 filtering facepiece respirators and medical masks are commonly used for protection against respiratory infections in healthcare settings, more clinical evidence is needed to understand the optimal settings and exposure circumstances for healthcare personnel to use these devices. A lack of clinically germane research has led to equivocal, and occasionally conflicting, healthcare respiratory protection recommendations from public health organizations, professional societies, and experts.

Methods: The Respiratory Protection Effectiveness Clinical Trial (ResPECT) is a prospective comparison of respiratory protective equipment to be conducted at multiple U.S. study sites. Healthcare personnel who work in outpatient settings will be cluster-randomized to wear N95 respirators or medical masks for protection against infections during respiratory virus season. Outcome measures will include laboratory-confirmed viral respiratory infections, acute respiratory illness, and influenza-like illness. Participant exposures to patients, coworkers, and others with symptoms and signs of respiratory infection, both within and beyond the workplace, will be recorded in daily diaries. Adherence to study protocols will be monitored by the study team.

Discussion: ResPECT is designed to better understand the extent to which N95s and MMs reduce clinical illness among healthcare personnel. A fully successful study would produce clinically relevant results that help clinician-leaders make reasoned decisions about protection of healthcare personnel against occupationally acquired respiratory infections and prevention of spread within healthcare systems.

Trial registration: The trial is registered at clinicaltrials.gov, number NCT01249625 (11/29/2010).

Keywords: Healthcare personnel; Influenza; Masks; Respirators; Respiratory infections.

References

    1. Sepkowitz KA. Occupationally acquired infections in health care workers. Part I. Ann Intern Med. 1996;125(10):826–34. doi: 10.7326/0003-4819-125-10-199611150-00007.
    1. Sydnor E, Perl TM. Healthcare providers as sources of vaccine-preventable diseases. Vaccine. 2014;32(38):4814–22. doi: 10.1016/j.vaccine.2014.03.097.
    1. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Health Care Infection Control Practices Advisory Committee 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007;35 Suppl 2:65–164. doi: 10.1016/j.ajic.2007.10.007.
    1. Institute of Medicine . Preparing for and influenza pandemic: personal protective equipment for healthcare workers. Washington: National Academies Press; 2008.
    1. Archibald LK, Jarvis WR. Health care- associated infection outbreak investigations by the Centers for Disease Control and Prevention, 1946–2005. Am J Epidemiol. 2011;174(Suppl 11):47–64. doi: 10.1093/aje/kwr310.
    1. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in health care settings. Clin Infect Dis. 2003;37:1094–101. doi: 10.1086/378292.
    1. Chan LY, Wong JT, Li PK, Lui SF, Fung H, Sung J. Risk of transmission of severe acute respiratory syndrome to household contacts by infected health care workers and patients. Am J Med. 2004;116(8):559–60. doi: 10.1016/j.amjmed.2003.11.011.
    1. Torner N, Solano R, Rius C, Domínguez A. Surveillance network of Catalonia Spain TM. Implication of health care personnel in measles transmission. Hum Vaccin Immunother. 2015;11(1):288–92. doi: 10.4161/hv.36166.
    1. Sartor C, Zandotti C, Romain F, Jacomo V, Simon S, Atlan-Gepner C, et al. Disruption of services in an internal medicine unit due to a nosocomial influenza outbreak. Infect Control Hosp Epidemiol. 2002;23:615–9. doi: 10.1086/501981.
    1. Miggins M, Hasan A, Hohmann S, Southwick F, Casella G, Schain D, et al. The potential influence of common viral infections diagnosed during hospitalization among critically ill patients in the United States. PLoS One. 2011;6 doi: 10.1371/journal.pone.0018890.
    1. Lioka F, Sada R, Maesako Y, Nakamura F, Ohno H. Outbreak of pandemic 2009 influenza A/H1N1 infection in the hematology ward: fatal clinical outcome of hematopoietic stem cell transplant recipients and emergence of the H275Y neuraminidase mutation. Int J Hematol. 2012;96:364–9. doi: 10.1007/s12185-012-1139-1.
    1. Monto AS. Epidemiology of viral respiratory infections. Am J Med. 2002;112(6A):4S–12. doi: 10.1016/S0002-9343(01)01058-0.
    1. Musher DM. How contagious are common respiratory tract infections? N Engl J Med. 2003;348(13):1256–66. doi: 10.1056/NEJMra021771.
    1. Wells WF. Aerodynamics of droplet nuclei. New York: Cambridge University Press; 1955. pp. 13–9.
    1. Cowling BJ, Ip DK, Fang VJ, Suntarattiwong P, Olsen SJ, Levy J, et al. Aerosol transmission is an important mode of influenza A virus spread. Nat Commun. 2013;4:1935. doi: 10.1038/ncomms2922.
    1. Cowling BJ, Ip DK, Fang VJ, Suntarattiwong P, Olsen SJ, Levy J, et al. Modes of transmission of influenza B virus in households. PLoS One. 2014;9(9) doi: 10.1371/journal.pone.0108850.
    1. Janssen L, Ettinger H, Graham S, Shaffer R, Zhuang Z. Commentary: the use of respirators to reduce inhalation of airborne biological agents. J Occup Environ Hyg. 2013;10(8):D97–103. doi: 10.1080/15459624.2013.799964.
    1. Lipp A, Edwards P. Disposable surgical face masks for preventing surgical wound infection in clean surgery. The Cochrane Library. 2014. .
    1. Oberg T, Brosseau LM. Surgical mask filter and fit performance. Am J Infect Control. 2008;36(4):276–82. doi: 10.1016/j.ajic.2007.07.008.
    1. Loeb M, Dafoe N, Mahony J, John M, Sarabia A, Glavin V, et al. Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA. 2009;302:1865–71. doi: 10.1001/jama.2009.1466.
    1. MacIntyre CR, Wang Q, Seale H, Yang P, Shi W, Gao Z, et al. A randomized clinical trial of three options for N95 respirators and medical masks in health workers. Am J Respir Crit Care Med. 2013;187(9):960–6. doi: 10.1164/rccm.201207-1164OC.
    1. MacIntyre CR, Wang Q, Rahman B, Seale H, Ridda I, Gao Z, et al. Efficacy of face masks and respirators in preventing upper respiratory tract bacterial colonization and co-infection in hospital healthcare workers. Prev Med. 2014;62:1–7. doi: 10.1016/j.ypmed.2014.01.015.
    1. Bessesen MT, Savor-Price C, Simberkoff M, Reich NG, Pavia AT, Radonovich LJ. N95 respirators or surgical masks to protect healthcare workers against respiratory infections: are we there yet? Am J Respir Crit Care Med. 2013;187(9):904–5. doi: 10.1164/rccm.201303-0581ED.
    1. Coffey CC, Campbell DL, Shuang Z. Simulated workplace performance of N95 respirators. Am Ind Hyg Assoc. 1999;60:618–24. doi: 10.1080/00028899908984481.
    1. Liverman CT, Harris TA, Rogers MEB, Shine KI. Respiratory protection for healthcare workers in the workplace against novel H1N1 influenza A: a letter report. National Academies Press; 2009, p. 1–68.
    1. Duling MG, Lawrence RB, Slaven JE, Coffey CC. Simulated workplace protection factors for half-facepiece respiratory protective devices. J Occup Environ Hyg. 2007;4(6):420–31. doi: 10.1080/15459620701346925.
    1. Grinshpun SA, Haruta H, Eninger RM, Reponen T, McKay RT, Lee SA. Performance of an N95 filtering facepiece particulate respirator and a surgical mask during human breathing: two pathways for particle penetration. J Occup Environ Hyg. 2009;6(10):593–603. doi: 10.1080/15459620903120086.
    1. Van der Sande M, Teunis P, Sabel R. Professional and home-made face masks reduce exposure to respiratory infections among the general population. PLoS One. 2008;3(7) doi: 10.1371/journal.pone.0002618.
    1. Radonovich LJ, Jr, Cheng J, Shenal BV, Hodgson M, Bender BS. Respirator tolerance in health care workers. J Am Med Assoc. 2009;301(1):36–8. doi: 10.1001/jama.2008.894.
    1. Shenal BV, Radonovich LJ, Jr, Cheng J, Hodgson M, Bender BS. Discomfort and exertion associated with prolonged wear of respiratory protection in a health care setting. J Occup Environ Hyg. 2012;9:59–64. doi: 10.1080/15459624.2012.635133.
    1. Gosch ME, Shaffer RE, Eagan AE, Roberge RJ, Davey VJ, Radonovich LJ. B95: a new respirator for health care personnel. Am J Infect Control. 2013;41(12):1224–30. doi: 10.1016/j.ajic.2013.03.293.
    1. Bailar JC, Brosseau LM, Cohen HJ, et al. Reusability of facemasks during an influenza pandemic: facing the flu. Washington: Institute of Medicine, National Academies Press; 2006.
    1. Baig AS, Knapp C, Eagan AE, Radonovich LJ., Jr Health care workers’ views about respirator use and features that should be included in the next generation of respirators. Am J Infect Control. 2010;38(1):18–25. doi: 10.1016/j.ajic.2009.09.005.
    1. Chor JS, Pada SK, Stephenson I, Goggins WB, Tambyah PA, Medina M, et al. Differences in the compliance with hospital infection control practices during the 2009 influenza H1N1 pandemic in three countries. J Hosp Infect. 2012;81(2):98–103. doi: 10.1016/j.jhin.2012.04.003.
    1. Institute of Medicine Committee on Respiratory Protection for healthcare workers in the workplace against novel H1N1 influenza A. In: Liverman CT, Harris TA, Rogers MEB, Shine KI, editors. Respiratory protection for healthcare workers in the workplace against novel H1N1 Influenza A: a letter report. Washington: National Academies Press; 2009.
    1. SHEA, IDSA, APIC. Letter to President Obama on Federal PPE Guidance. 2009. . Accessed 28 Sept 2015.
    1. Centers for Disease Control and Prevention. Interim recommendations for facemask and respirator use to reduce 2009 influenza A (H1N1) virus transmission. 2009. . Accessed 28 Sept 2015.
    1. Centers for Disease Control and Prevention. 2007 guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. 2007. . Accessed 28 Sept 2015.
    1. Centers for Disease Control and Prevention. Prevention strategies for seasonal influenza in healthcare settings, 2013. Available at: . Accessed 28 Sept 2015.
    1. Roberge RJ, Kim JH, Powell JB, Shaffer RE, Ylitalo CM, Sebastian JM. Impact of low filter resistances on subjective and physiological responses to filtering facepiece respirators. PLoS One. 2013;8(12) doi: 10.1371/journal.pone.0084901.
    1. Boyce JM, Pittet D, Healthcare Infection Control Practices Advisory Committee Society for Healthcare Epidemiology of America. Association for Professionals in Infection Control. Infectious Diseases Society of America. Hand Hygiene Task Force: Guideline for hand Hygiene in Health-Care Settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol. 2002;23 Suppl 12:3–40. doi: 10.1086/503164.
    1. de la Tabla VO, Masiá M, Antequera P, Martin C, Gazquez G, Buñuel F, et al. Comparison of combined nose-throat swabs with nasopharyngeal aspirates for detection of pandemic influenza A/H1N1 2009 virus by real-time reverse transcriptase PCR. J Clin Microbiol. 2010;48(10):3492–5. doi: 10.1128/JCM.01105-10.
    1. Heikkinen T, Marttila J, Salmi AA, Ruuskanen O. Nasal swab versus nasopharyngeal aspirate for isolation of respiratory viruses. J Clin Microbiol. 2002;40(11):4337–9. doi: 10.1128/JCM.40.11.4337-4339.2002.
    1. Heikkinen T, Salmi AA, Ruuskanen O. Comparative study of nasopharyngeal aspirate and nasal swab specimens for detection of influenza. BMJ. 2001;322(7279):138. doi: 10.1136/bmj.322.7279.138.
    1. Lambert SB, Whiley DM, O’Neill NT, Andrews EC, Canavan FM, Bletchly C, et al. Comparing nose-throat swabs and nasopharyngeal aspirates collected from children with symptoms for respiratory virus identification using real-time polymerase chain reaction. Pediatrics. 2008;122(3):e615–20. doi: 10.1542/peds.2008-0691.
    1. Schmidt NJ, Emmons RW. Diagnostic procedures for viral, rickettsial, and chlamydial infections. 6. Washington: American Public Health Association, Inc.; 1989.
    1. Kendal AP, Pereira MS, Skehel JJ. Concepts and procedures for laboratory based influenza surveillance. Atlanta: World Health Organization Collaborating Centers for Reference and Research in Influenza, Centers for Disease Control; 1982.
    1. Reich NG, Obeng D. ClusterPower: power calculations for cluster-randomized and cluster-randomized crossover trials. R package version 0.5. 2013. . Accessed 28 Sep 2015.
    1. Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039–46. doi: 10.1001/jamainternmed.2013.9763.
    1. Hayes RJ, Alexander ND, Bennett S, Cousens SN. Design and analysis issues in cluster-randomized trials of interventions against infectious diseases. Stat Methods Med Res. 2000;9(2):95–116. doi: 10.1191/096228000670953670.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다